Steric Control of Cooperative Anion Transport Mediated by β- and δHexachlorocyclohexane Multivalent Carriers

Ioan Stroia1, Andreea Oanea1,2, Niculina Hadade2

  • 1Institut Européen des Membranes, Adaptive Supramolecular Nanosystems Group, University of Montpellier, ENSCM, CNRS, UMR5635, Place E. Bataillon CC047, 34095 Montpellier, France.

JACS Au
|May 29, 2026
PubMed

The β- and δ-hexachlorocyclohexane (HCH) diastereoisomers display triaxial C-H donor sites, favorably oriented for anion binding via weak hydrogen bonding (HB), prompting us to investigate their transmembrane anion transport properties. Notably, we found that only δ-HCH facilitates efficient Cl- translocation via a cooperative carrier mechanism (EC50 = 1.78 mol % (8.25 μM)), while β-HCH shows no measurable activity under the same conditions. Although both isomers exhibit comparable binding affinities in solution, the steric hindrance in β-HCH likely prevents formation of the cooperative HB interactions required to offset the chloride dehydration penalty during translocation across the membrane, rendering β-HCH inactive toward Cl- transport. Both β- and δ-HCH display high Br- and NO3 - transport activity, with δ-HCH showing higher efficiency, consistent with a cooperative binding mode. Notably, δ-HCH also induces membrane depolarization in liposome models by mediating voltage-responsive Cl- transport down its electrochemical gradient. Together, our experimental and theoretical results illustrate how steric accessibility can control cooperativity of multivalent weak HB C-H donor carriers, resulting in an efficient anion transport.

Related Concept Videos

Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct microscopic...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Secondary Active Transport01:32

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...